Independent AI agent reference

Air AI vs Suki

A side-by-side comparison of capabilities, autonomy, integrations, and pricing to help you choose.

Short answer: choose Air AI if you want defunct ai voice agent; subject of a 2026 ftc enforcement settlement (Autonomous agent, enterprise); choose Suki if you want ai voice assistant and ambient scribe for clinicians (Copilot, subscription).

Air AISuki
What it isDefunct AI voice agent; subject of a 2026 FTC enforcement settlementAI voice assistant and ambient scribe for clinicians
Typeagentproduct-with-agents
AutonomyAutonomous agentCopilot
Pricingenterprisesubscription
Best forsmbmid-market, enterprise
Deploymentsaassaas, api
Modalitiesvoicevoice, text
Modelsproprietaryproprietary
Protocolsnonerest-api
Integrations-Epic, Oracle Health (Cerner), athenahealth, MEDITECH, Zoom
Capabilities2 documented4 documented

Air AI

  • +2023 demos were unusually natural and long-duration for the era and reached a wide audience
  • -Defunct: no live product, and the air.ai domain now belongs to an unrelated company
  • -Subject of an FTC enforcement action and 2026 settlement banning the owners from marketing business opportunities
Full Air AI profile

Suki

  • +Multimodal beyond scribing: dictation, voice commands, and chart Q&A
  • +Broad EHR integration, including an ambient interface with Epic and a Zoom partnership
  • +Established player with real health-system traction
  • -List pricing is not officially published (only third-party estimates)
  • -Documentation and coding output are drafts requiring clinician review and carry clinical-accuracy risk
Full Suki profile

Which should you choose?

Air AI is defunct ai voice agent; subject of a 2026 ftc enforcement settlement, best for smb. Suki is ai voice assistant and ambient scribe for clinicians, best for mid-market, enterprise. The right choice depends on the autonomy level you want, your existing integrations, and your budget, all compared above.

This comparison is generated from the sourced Air AI and Suki profiles. Open either profile to review its evidence and last-reviewed date.